Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Investigational treatment for advanced melanoma to be studied

University of Illinois at Chicago researchers are participating in a multi-center research trial to evaluate the safety and effectiveness of Allovectin-7, an investigational treatment for advanced melanoma.

10 Jan 2008

RNA silences cancer suppressor gene

One way cancer arises is when tumor suppressor genes that normally keep cell growth in check are mysteriously turned off.

10 Jan 2008

microRNA molecules block breast cancer's ability to spread

Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis.

10 Jan 2008

Intensity modulated radiation therapy

Newly diagnosed cancer patients should spend as much time researching a radiation treatment facility as they would spend picking out a new car or a home.

10 Jan 2008

Multiple behavioral risks for skin cancer among U.S. adults

Whether you're basking on the beach during vacation, coasting down glittering white snow on a weekend ski trip, or simply walking the dog or running errands, sunlight's ultraviolet rays can damage your skin year-round.

9 Jan 2008

New test for newly diagnosed breast cancer

A new test that can predict whether a patient’s cancer will spread beyond the breast site has been developed by scientists at the UCD Conway Institute, University College Dublin and St Vincent’s University Hospital, Dublin, Ireland.

8 Jan 2008

Generation Y complacent about risk of melanoma

Generation Y is becoming more complacent about the risk of melanoma and other types of skin cancer, according to a University of New South Wales (UNSW) researcher.

7 Jan 2008

Benefits of short-term hormonal therapy for men receiving radiation therapy for prostate cancer far outweigh the risks

Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years - especially the development of bone metastases - and increased survival in older men with potentially aggressive prostate cancer.

4 Jan 2008

FDA reviews new data on risks of erythropoiesis-stimulating agents

The U.S. Food and Drug Administration (FDA) is reviewing new data from two studies that provide further evidence of the risks of anemia drugs known as erythropoiesis-stimulating agents, or ESAs.

4 Jan 2008

FDA approves Hi-Flex mobile bearing knee prostheses

Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.

3 Jan 2008

Highlights of pulmonary and critical care symposium

New perspectives on lung cancer screening, complications of sleep apnea, cystic fibrosis, and other key topics in pulmonary and critical care medicine are presented in the special January issue of The American Journal of Medical Sciences, published by the Southern Society for Clinical Investigation and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, provider of leading healthcare content, context and consulting.

3 Jan 2008

Gene variation increases risk of liver tumor in patients with cirrhosis

A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death.

2 Jan 2008

FASgen announces new discoveries in lung cancer

FASgen is pleased to report the publication of important research results for lung cancer treatment using FAS093, one of the Company's proprietary compounds.

2 Jan 2008

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

2 Jan 2008

Treating often ignored non-cancer health issues after cancer diagnosis prolongs survival

Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.

28 Dec 2007

Study shows that antiangiogenic agent delays progression of advanced breast cancer

The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.

28 Dec 2007

Bevacizumab found to improve survival for patients with advanced breast cancer

Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.

28 Dec 2007

Advanced melanoma - new treatment

20 Dec 2007

Researchers initiate gene therapy trial in patients with advanced skin cancer

Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center are the first in the region to have joined a nationwide clinical trial to evaluate the effectiveness of a gene therapy in patients with advanced melanoma which is aimed to help a patient ' s own immune system fight their cancer.

18 Dec 2007

Tumors less than 1 centimeter in size can be aggressive and may require maximum therapy

Breast tumors that are 1 centimeter in size or smaller - no more than 0.4 inch in length - can still be very aggressive and may require more intensive therapy than is routinely offered today, say researchers at Mayo Clinic in Jacksonville, Fla.

17 Dec 2007